SEC Filing Details Document Details Form 3 Filing Date Feb 7, 2023 Document Date Feb 6, 2023 Form Description Initial filing by director officer or owner of more than ten percent. Filing Group 3,4,5 Company Karuna Therapeutics Issuer Karuna Therapeutics, Inc. Filer KANE WILLIAM P JR Filing Formats View HTML Download PDF Download DOC Download XLS Print Page Email Page RSS Feeds Email Alerts